SVQ Intrinsic Valuation and Fundamental Analysis - Sinovac Biotech Ltd

Watchlist Manager

Watchlist

Price: 5.58 EUR Market Closed

Market Cap: €556m

	Sinovac Biotech Ltd F:SVQ	CN
	Steppe Gold Ltd F:2J9	CA

Intrinsic Value

SVQ price has not been updated for more than 3 years. This may indicate that the stock has been delisted.

The intrinsic value of Sinovac Biotech Ltd (SVQ) under the Base Case is 5.17 EUR per share. Compared with the current market price of 5.58 EUR, the stock appears Overvalued by 7% .

The intrinsic value is calculated using the DCF method.

Do our valuations actually work? See backtest results .

SVQ Intrinsic Value

Overvaluation 7%

Intrinsic Value

Price €5.58

Track Buy Zone

20% below Intrinsic Value €4.14

Get notified when the price drops into your buy zone

Current Price €5.58

Intrinsic Value €5.17

Margin of Safety 20% €4.14

Or choose another margin of safety

0% below Intrinsic Value

10% below Intrinsic Value

30% below Intrinsic Value

40% below Intrinsic Value

50% below Intrinsic Value

Custom

Fundamental Analysis

What Sinovac Biotech Does

Biotechnology Health Care

Sinovac Biotech is a vaccine company that develops, makes, and sells vaccines for infectious diseases. Its products are used in public vaccination programs and by hospitals, clinics, and distributors that supply immunization needs. The company’s portfolio includes vaccines for diseases such as hepatitis, influenza, varicella, hand-foot-and-mouth disease, and COVID-19.

Headquarters: China CN
Employees: 3 037
IPO date: Nov 13, 2009